Home » Topics » BioWorld Science

BioWorld Science
RSS

Biogen enters agreement to acquire stroke drug candidate from TMS

June 8, 2018

FDA awards orphan drug designation to brincidofovir for the treatment of smallpox

June 8, 2018

Selinexor liposarcoma trial advances after improvement seen in progression-free survival

June 7, 2018

Enrollment ongoing in phase III study of pertuzumab and trastuzumab fixed-dose combination

June 7, 2018

GlaxoSmithKline initiates phase I study of GSK-3858279

June 7, 2018

Phase II results presented for TAK-954 in patients with enteral feeding intolerance

June 7, 2018

Athersys expands its collaboration with Healios

June 7, 2018

EMA grants PRIME designation for dilanubicel

June 7, 2018

FDA grants orphan drug designation to TransCon PTH

June 7, 2018

4D pharma and MSD collaborate to study Keytruda and MRx-0518 combination in solid tumors

June 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...